NASDAQ$NUTX

Nutex Health Inc · Q3 2014 earnings

Q3 2014 earnings ·

Headline financials

Total Revenue

$755K

Previous: $755K+0.0%
Capital Expenditures

-$2.03K

Previous: -$6.45K+68.6%
Free Cash Flow

-$184K

Previous: -$152K-21.1%
Net Income

-$186K

Previous: -$158K-17.4%
Operating Income

-$184K

Previous: -$158K-16.5%
Gross Profit

$154K

Previous: $263K-41.5%

Revenue & EPS history

Nutex Health Inc · Revenue · Quarterly

$755K

Q3 2014+0%vs Q3 2013

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports

Historical avg

+1.9%

Avg return

Earnings day

+17.2%

Avg return

5 days after

+21.1%

Avg return

30 days after

62%

8 / 13 earnings

Positive

+22.4%

Q1 2022

Best reaction

-14.3%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+6.4%+8.0%+14.4%
Q4 2025-14.3%-14.1%-4.2%
Q3 2025+0.0%+32.9%+64.1%
Q1 2025+1.0%+40.2%+0.2%
Q3 2024+6.3%+38.2%+39.3%
Q2 2024+0.9%+62.7%+173.1%
Q1 2024+6.2%+14.8%+0.7%
Q3 2023+0.0%-6.0%-22.8%
Q2 2023+3.6%+0.9%-20.1%
Q1 2023+8.9%+10.3%-17.8%
Q3 2022-9.2%+1.7%+59.7%
Q2 2022-8.2%-27.9%-53.8%
Q1 2022+22.4%+61.8%+41.2%
Q3 2021
Q2 2021
Q1 2021
Q3 2020
Q1 2020
Q3 2019
Q1 2019
Q2 2018
Q2 2016
Q3 2014
Q1 2014
Q3 2013
Q2 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro